Based on the study by Petito da Silva et al., empagliflozin has been shown to increase insulin sensitivity when given for five weeks in diet-induced NAFLD in C57Bl/6 mice [21]. Here, INS is linked to metabolic dysfunction-associated steatotic liver disease.